Monday, 26 September 2016

Antioxidant Lipoic Acid Appears to Slow SPMS Patients’ Neurodegeneration

Source Multiple Sclerosis News Today:

A pilot study exploring the antioxidant lipoic acid in patients with secondary progressive multiple sclerosis (SPMS) demonstrated that treatment for two years reduced the speed of brain tissue loss and improved the patients’ walking speed.  Read on.